Before being allowed to do these innovative operations as Cypass, the doctor must take efforts to master this innovative approach for making this method in the future a regular medical practice.
PART 1
… The stents iStent and Cypass – it’s like comparing the Blackberry to an iPhone.
And this “iPhone” is covered by insurance, as well, at the time of the removal of cataracts?
I don’t know exactly, but it seems to me yes.
So you have become a master of this new innovation?
Readers should not get the impression that Benjamin Eye is reaching for every novelty treatment that comes by and rushing head-on into traffic. I’m pretty conservative. It often happens that this or that new thing is presented as being perfect, but it doesn’t take long to figure out that’s far from the case. We never blindly introduce new, innovative products and only accept new methods that have been approved. And in order to find out if something like this is as good as it’s advertised, you sometimes wait a year-and-a-half.
How does it all work? There’s a new and well-proven method, similar to Cypass for example. Do you need a license?
The company will approve surgeons based on their experience with stents and general expertise. A representative of the company comes to see how you operate, what kind of instruments you have, and what results are like. And if they see that this doctor can be entrusted with this new technology – considering their reputation, as well – they will teach you how to use it, starting with a series of operations on hogs’ eyes. Then you operate on patients under supervision. If everything goes well, you get a license. Patients are told right off-the-bat, “This is the first, fifth, tenth time, etc. that this doctor has performed the operation”. Here, that period of time has long since passed and the procedure is in full-swing.
If I understand correctly, a representative of the company is actually present during the initial operations?
Yes, that’s the standard. A clinical instructor comes who has a lot of experience with different doctors implementing this technology. Companies like Alcon choose reliable surgeons; they don’t go to just anyone. Life goes on, and in ten years it’s already being taught in residencies, and this former innovation becomes a regular medical procedure. But our patients, fortunately, do not have to wait this long.
V. Kaufman
We are proud to offer our patients the latest in premium cataract surgery with non-diffractive EDOF IOL’s. Our experienced surgeons will work with you to determine the best lens option for your needs and provide you with the best possible outcome.
At Benjamin Eye Institute, we pride ourselves in staying at the forefront of innovative eye care solutions, consistently delivering high-quality services to our patients. One such advanced solution we offer is the Minimally Invasive Glaucoma Surgery (MIGS), an effective treatment method that has significantly transformed the management of glaucoma.
We're thrilled to announce that our practice is now offering same-day bilateral cataract surgery for well-qualified patients! This groundbreaking development has become possible due to remarkable advancements in cataract treatment technologies and their seamless integration. As a result, patients can now enjoy safer, faster, and more precise cataract surgeries with predictable outcomes. Let's dive into the details of this exciting new offering and how it is transforming the eye care industry.
Discover the Benefits of the MIGS OMNI Surgical System in Glaucoma Management, as Recommended by Dr. Arthur Benjamin
Dr. Arthur Benjamin's Approach to Endoscopic Cyclophotocoagulation and OMNI Viscocanalostomy
Good news for individuals who have already received a glaucoma diagnosis. You see as long as the retina and the brain are communicating with one another through signals. You lose your sight when the conversation ends. So what, it would seem? Additionally, there is an opportunity to develop medicines based on this process, perhaps with gene therapy. Due to the disease's progression, this will aid in maintaining vision.
There will be no loud statements that ophthalmology has high hopes for marijuana. But we will not deny some effect on intraocular pressure in glaucoma. For more details read on!
According to a statistic, there is a 20% probability that you have glaucoma if you are over 65. Older than 70 – 30%. Older than 85 – 40%
However, there are specific ethnic groupings where the likelihood is higher. African-Americans, Russian Jews, Poles, Lithuanians, and other Eastern Europeans need routine check-ups because they are at a higher risk.
